Editorial: Appropriate Use Recommendations for Lecanemab
- PMID: 37357273
- DOI: 10.14283/jpad.2023.34
Editorial: Appropriate Use Recommendations for Lecanemab
Conflict of interest statement
Dr. Rafii reports personal fees from AC Immune, Alzheon, Aptah Bio, Biohaven, Keystone Bio and grants from Eisai and Lilly, outside the submitted work.
Comment on
- 
  
  Aducanumab: Appropriate Use Recommendations.J Prev Alzheimers Dis. 2021;8(4):398-410. doi: 10.14283/jpad.2021.41. J Prev Alzheimers Dis. 2021. PMID: 34585212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
